Groundwater electro-bioremediation via diffuse electro-conductive zones: A critical review.

Microbial electrochemical technologies (MET) can remove a variety of organic and inorganic pollutants from contaminated groundwater. However, despite significant laboratory-scale successes over the past decade, field-scale applications remain limited. We hypothesize that enhancing the electrochemical conductivity of the soil surrounding electrodes could be a groundbreaking and cost-effective alternative to deploying numerous high-surface-area electrodes in short distances.

Severe nephrotoxicity during high-dose methotrexate administration in an adolescent with acute lymphoblastic leukemia.

High-dose methotrexate is an effective and safe therapy. It is included in the treatment regimens of various hematologic and oncologic diseases. The acute and severe toxicity of this chemotherapeutic agent is unusual.

Outdoor mesoscale fabricated ecosystems: Rationale, design, and application to evapotranspiration.

The disparity in scale, complexity, and control level between laboratory experiments and field observational studies has shaped both the methodologies employed and the nature of the research questions pursued in ecology and hydrology. While lysimeters and fabricated ecosystems suitably fit in this gap, their use as mesoscale experimental facilities has not been fully explored because of the limited manipulating capabilities and integration with imaging and monitoring methods, particularly for soil functioning. The proposed fabricated ecosystem (4.

Search for Leptonic Decays of Dark Photons at NA62.

The NA62 experiment at CERN, configured in beam-dump mode, has searched for dark photon decays in flight to electron-positron pairs using a sample of 1.4×10^{17} protons on dump collected in 2021. No evidence for a dark photon signal is observed.

Clonal Myeloproliferative Disorders in Patients with Down Syndrome-Treatment and Outcome Results from an Institution in Argentina.

Children with Down syndrome (DS) are at an increased risk of developing clonal myeloproliferative disorders. The balance between treatment intensity and treatment-related toxicity has not yet been defined. We analyzed this population to identify risk factors and optimal treatment.